体外膜肺氧合引起炎性反应治疗的研究进展

Advances in the treatment of inflammatory reaction induced by extracorporeal membrane oxygenation

体外膜肺氧合(ECMO)在很多危重症患者中可以提供心肺功能的支持,但是ECMO本身可引起全身炎性反应,导致急性肾衰竭及多脏器功能障碍等的风险增加,影响患者的预后。本文针对ECMO治疗中炎性反应的机制、危害及治疗措施的进展进行综述,以期为减轻ECMO相关炎性反应,改善患者临床预后,以及为后续研究提供思路。

Extracorporeal membrane oxygenation(ECMO)can provide support for cardiopulmonary function in many critically ill patients,but ECMO itself can cause systemic inflammatory reaction,lead to acute renal failure,multiple organ failure and other risks,and affect the prognosis of patients.This article reviews the mechanism,harm and treatment of inflammatory reaction in ECMO treatment,with a view to providing ideas for alleviating the inflammatory reaction associated with ECMO,improving clinical prognosis and follow-up research.